Muharrem Dagli

Muharrem Dagli

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2007 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
MDMuharrem Dagli
Muharrem Dagli
ISI Sati
I Sati
AAA Acar
A Acar
RSR E Stone
R E Stone
GDG Dursun
G Dursun
AEA Eryilmaz
A Eryilmaz
Objective: The aim of this study was to evaluate the outcomes of therapeutic intervention in patients with mutational falsetto, by applying perceptual and acoustic analysis before and after voice therapy.Materials and methods: Forty-five consecutive patients with mutational falsetto were studied retrospectively. Acoustic analysis (i.e. fundamental frequency, jitter, shimmer, and formants one, two and three) was performed using the Multi-Dimensional Voice Program. Perceptual voice analyses were performed, including graded severity–roughness–breathiness–aesthenicity–strain assessment.Results: Subjects' fundamental frequency, voice formants one, two and three, jitter, and shimmer were greater before than after treatment. There were statistically significant differences between pre- and post-treatment average values for fundamental frequency, jitter and shimmer. There were also statistically significant differences between pre- and post-treatment average values for formants one and two. These results were maintained after six months of follow up, and there was no significant difference between results at three- and six-month follow up. According to perceptual evaluation, each subject's voice had altered from mutational falsetto to chest voice by completion of the intervention. Thus, all of the patients successfully lowered their modal speaking voice to an appropriate level.Conclusion: In the light of objective evaluations, and by applying the study treatment protocol, these results suggest that normal voice can be maintained after intervention, at six months' follow up.

9 November 2006 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
MDMuharrem Dagli
Muharrem Dagli
FAFiliz Sivas Acar
Filiz Sivas Acar
HKHayriye Karabulut
Hayriye Karabulut
AEAdil Eryilmaz
Adil Eryilmaz
EIEsra Erkol Inal
Esra Erkol Inal

24 November 2006 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
AEA Eryilmaz
A Eryilmaz
MDMuharrem Dagli
Muharrem Dagli
HKH Karabulut
H Karabulut
FAF Sivas Acar
F Sivas Acar
EIE Erkol Inal
E Erkol Inal
CGC Gocer
C Gocer
Aims: The aim of this study was to investigate hearing loss in patients with ankylosing spondylitis.Study design: Prospective, case–control study.Methods: Fifty-nine ankylosing spondylitis patients (118 ears) and 52 healthy control subjects (104 ears) were included. Pure tone audiometry at 250, 500, 1000, 2000, 4000 and 6000 Hz and immittance measures, including tympanometry and acoustic reflex tests, were performed in the patients and controls.Results: Sensorineural hearing loss was found in 21 patients (35.5 per cent), bilateral in 15 patients and unilateral in six. Pure tone thresholds significantly differed between patients and controls at all frequencies (p<0.05). There was no statistically significant difference between the right and the left ears' thresholds at all frequencies, except at 4000 Hz in ankylosing spondylitis patients. The right ears' thresholds were higher than those of the left ears. Patients' pure tone average (PTA) thresholds were significantly different from those of controls in all three PTA groups (i.e. 250 Hz; 500, 1000 and 2000 Hz; and 4000 and 6000 Hz) (p<0.05). The differences were most prominent in the higher frequencies.Conclusion: Our findings suggest a decreased hearing level in ankylosing spondylitis patients, mostly at high frequencies, although the pure tone thresholds of patients and controls significantly differed at all frequencies.

1 January 2008 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
MDMuharrem Dagli
Muharrem Dagli
NGNebil Goksu
Nebil Goksu
AEAdil Eryilmaz
Adil Eryilmaz
GKGamze Mocan Kuzey
Gamze Mocan Kuzey
YBYildirim Bayazit
Yildirim Bayazit
CGCelil Gocer
Celil Gocer

1 September 2008 in Auris Nasus Larynx
Verified
Journal Article
Closed access
MDMuharrem Dagli
Muharrem Dagli
AEAdil Eryilmaz
Adil Eryilmaz
STSalih Tanrikulu
Salih Tanrikulu
AAAcar Aydin
Acar Aydin
MGMuzeyyen Gonul
Muzeyyen Gonul
CGCelil Gocer
Celil Gocer

26 October 2009 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
HKH Karabulut
H Karabulut
MDMuharrem Dagli
Muharrem Dagli
AAA Ates
A Ates
YKY Karaaslan
Y Karaaslan
The aim of the current study was to investigate hearing loss and cochlear function in patients with systemic lupus erythematosus, using audiology, distortion product otoacoustic emissions and transient evoked otoacoustic emissions.Study design: : Prospective, case–control study.Methods: : The study included 26 randomised patients with systemic lupus erythematosus (52 ears) and 30 healthy control subjects (60 ears). Pure tone audiometry was performed at 250 and 500 Hz and at 1, 2, 4, 6, 8, 10, 12, 14 and 16 kHz. Distortion product otoacoustic emissions and transient evoked otoacoustic emissions were measured using Biologic System equipment with Scout Acoustic Emissions System software.Results: : The distortion product otoacoustic emission signal responses were significantly different only at 750 Hz, while the distortion product otoacoustic emission signal–noise ratios were significantly different at 750 Hz and 6 kHz (p < 0.05), comparing patients and controls. The transient evoked otoacoustic emission signal–noise ratios were significantly different at 2 and 3 kHz, comparing patients and controls (p < 0.05). The transient evoked otoacoustic emission total signal–noise ratios were significantly different, comparing patients and controls (p < 0.05). In addition, the pure tone audiometry thresholds were significantly different at 250 and 500 Hz and at 1, 2, 10 and 12 kHz, comparing patients and controls (p < 0.05).Conclusion: : Our findings do not completely agree with those of previous temporal bone histopathological studies. However, our results do support a general picture of low frequency hearing loss in systemic lupus erythematosus patients. We consider these results to be related to endolymphatic and cochlear hydrops, and we suggest that electrocochleography could be performed in further studies for clarification of this subject.